| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2000;120:520-527
© 2000 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology |
From the Department of Anesthesiology, University of Milano, Division of Cardiac Anesthesia and Intensive Care,a Epidemiology Unit,b and Division of Cardiac Surgery,c San Raffaele Hospital, Milano, Italy.
Address for reprints: Valter Casati, MD, Division of Cardiac Anesthesia and Intensive Care, Policlinico di Monza, via Amati 111, Monza, 20052, Milano, Italy (E-mail: v_casati{at}hotmail.com ).
Objective: Since excessive fibrinolysis during cardiac surgery is frequently associated with abnormal perioperative bleeding, many authors have advocated prophylactic use of antifibrinolytic drugs to prevent hemorrhagic disorders. We compared the effects of tranexamic acid (a synthetic antifibrinolytic drug) with aprotinin (a natural derivative product with antifibrinolytic properties) on perioperative bleeding and the need for allogeneic transfusions.
Methods: In a single-center prospective randomized unblinded trial, 1040 consecutive patients undergoing primary, elective cardiac operations with cardiopulmonary bypass received either high-dose aprotinin or tranexamic acid. The aprotinin group (518 patients) received 280 mg in 20 minutes before the skin incision, 280 mg in the priming solution of the extracorporeal circuit, and a continuous infusion of 70 mg/h throughout the operation. The tranexamic acid group (522 patients) received 1 g in 20 minutes before the skin incision, 500 mg in the priming solution of the extracorporeal circuit, and a continuous infusion of 400 mg/h during the operation. Postoperative bleeding, perioperative transfusions, and hematologic variables were evaluated at fixed times. Postoperative thrombotic complications, intubation time, intensive care unit stay, and hospital stay were recorded.
Results: Postoperative bleeding was similar in the 2 groups: aprotinin 250 mL (150-400 mL) versus tranexamic acid 300 mL (200-450 mL) (median and 25th-75th quartiles), median difference of 50 mL (95% confidence intervals, 0-50 mL). The number of transfusions and the outcome did not differ.
Conclusions: Tranexamic acid and aprotinin show similar clinical effects on bleeding and allogeneic transfusion in patients undergoing primary elective heart operations. Since tranexamic acid is about 100 times cheaper than aprotinin, its use is preferable in this type of patient.
This article has been cited by other articles:
|
|
 |
|
  A. M. Mengistu, K. D. Rohm, J. Boldt, J. Mayer, S. W. Suttner, and S. N. Piper The Influence of Aprotinin and Tranexamic Acid on Platelet Function and Postoperative Blood Loss in Cardiac Surgery Anesth. Analg., August 1, 2008; 107(2): 391 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Casati, A. D'Angelo, L. Barbato, D. Turolla, F. Villa, M. A. Grasso, A. Porta, and F. Guerra Perioperative management of four anaemic female Jehovah's Witnesses undergoing urgent complex cardiac surgery Br. J. Anaesth., September 1, 2007; 99(3): 349 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mehr-Aein, M. Sadeghi, and M. Madani-civi Does Tranexamic Acid Reduce Blood Loss in Off-Pump Coronary Artery Bypass? Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): 285 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Brown, N. J.O. Birkmeyer, and G. T. O'Connor Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery Circulation, June 5, 2007; 115(22): 2801 - 2813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Baric, B. Biocina, D. Unic, Z. Sutlic, I. Rudez, V. B. Vrca, K. Brkic, and M. Ivkovic Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 366 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. McCrae, D. C. Matthews, and M. Linenberger Consultative hematology ASH Self-Assessment Program, January 1, 2007; 2007(1): 466 - 505. [Full Text] [PDF]
|
|
|
|
|
|
V. Casati, A. D'Angelo, L. Barbato, E. Rossi, M. A. Grasso, S. Spagnolo, and E. Panzeri Perioperative management of a heterozygous carrier of Glanzmann's thrombasthenia submitted to coronary artery bypass grafting with cardiopulmonary bypass. Anesth. Analg., August 1, 2006; 103(2): 309 - 11, table of contents. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Levy Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation Am. J. Health Syst. Pharm., September 15, 2005; 62(18_Supplement_4): S15 - S19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Akowuah, V. Shrivastava, B. Jamnadas, D. Hopkinson, P. Sarkar, R. Storey, P. Braidley, and G. Cooper Comparison of Two Strategies for the Management of Antiplatelet Therapy During Urgent Surgery Ann. Thorac. Surg., July 1, 2005; 80(1): 149 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Mahdy and N. R. Webster Perioperative systemic haemostatic agents Br. J. Anaesth., December 1, 2004; 93(6): 842 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Andreasen and C. Nielsen Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 311 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Casati, P. Della Valle, S. Benussi, A. Franco, C. Gerli, P. Baili, O. Alfieri, and A. D'Angelo Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 83 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Casati, S. Benussi, L. Sandrelli, M. A. Grasso, S. Spagnolo, and A. D'Angelo Intraoperative Moderate Acute Normovolemic Hemodilution Associated with a Comprehensive Blood-Sparing Protocol in Off-Pump Coronary Surgery Anesth. Analg., May 1, 2004; 98(5): 1217 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Shore-Lesserson, D. L. Reich, and D. H. Adams Invited commentary Ann. Thorac. Surg., February 1, 2004; 77(2): 642 - 643. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Avidan, E. L. Alcock, J. Da Fonseca, J. Ponte, J. B. Desai, G. J. Despotis, and B. J. Hunt Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery Br. J. Anaesth., February 1, 2004; 92(2): 178 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Karski and J. T. Balatbat Blood Conservation Strategies in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2003; 7(2): 175 - 188. [Abstract] [PDF]
|
|
|
|
|
|
H. Pleym, R. Stenseth, A. Wahba, L. Bjella, A. Karevold, and O. Dale Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery Anesth. Analg., April 1, 2003; 96(4): 923 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zabeeda, B. Medalion, M. Sverdlov, S. Ezra, A. Schachner, T. Ezri, and A. J. Cohen Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization Ann. Thorac. Surg., September 1, 2002; 74(3): 733 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.F. M. Bechtel, J. Prosch, H.-H. Sievers, and C. Bartels Is the kaolin or celite activated clotting time affected by tranexamic acid? Ann. Thorac. Surg., August 1, 2002; 74(2): 390 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Casati, L. Sandrelli, G. Speziali, G. Calori, M. A. Grasso, and S. Spagnolo Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1084 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shibata, S. Takamoto, Y. Kotsuka, and H. Sato Effectiveness of combined blood conservation measures in thoracic aortic operations with deep hypothermic circulatory arrest Ann. Thorac. Surg., March 1, 2002; 73(3): 739 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Nuttall, D. N. Fass, L. J. Oyen, W. C. Oliver Jr., and M. H. Ereth A Study of a Weight-Adjusted Aprotinin Dosing Schedule During Cardiac Surgery Anesth. Analg., February 1, 2002; 94(2): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Casati Is it the time to avoid routine application of blood products in cardiac surgery? Eur. J. Cardiothorac. Surg., January 1, 2002; 21(1): 160 - 161. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Despotis, M. S. Avidan, and C. W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann. Thorac. Surg., November 1, 2001; 72(5): S1821 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Casati, C. Gerli, A. Franco, G. Torri, A. D'Angelo, S. Benussi, and O. Alfieri Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study Ann. Thorac. Surg., August 1, 2001; 72(2): 470 - 475. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
